期刊文献+

901例女性人乳头瘤病毒感染状况及基因型分布的调查 被引量:4

A survey on the infection and genotype distribution of human papilloma virus of 901 female
原文传递
导出
摘要 目的探讨高低危型人乳头瘤病毒(human papilloma virus,HPV)在不同年龄段的感染情况,为防治宫颈癌、尖锐湿疣等HPV相关疾病提供理论依据。方法收集有HPV感染临床检测指征(宫颈炎、宫颈上皮内瘤变及宫颈癌)的女性标本901例,利用导流杂交基因芯片技术对阴道分泌物进行HPV分型检测。结果901例标本HPV阳性率为41.73%,其中单纯高、低危型HPV和高低危型HPV混合感染率分别为60.90%(229/376)、23.67%(89/376)和15.43%(58/376);高危型HPV感染各个年龄段的感染率为26.39%~42.19%,低危型HPV感染各个年龄段的感染率为8.96%~39.19%,各型均呈现“U”型趋势。结论各年龄段主要感染型别为HPV16。低年龄段以高低危型HPV混合感染为主,≥55岁以单纯高危型HPV感染为主,单纯高危型HPV感染率随年龄增长而上升。 Objective To investigate the infection rate of high-risk and low-risk HPV in different age groups, and provide the theoretical foundation for preventing and treating the diseases caused by HPV, such as cervical cancer and condylomata acuminate. Methods Samples were collected from 901 female pa- tients with clinical indication for testing. The flow-through hybridization and gene chip were used to identifiy the subtypes. Results 376 cases were infected with HPV (41.73%) among the 901 patients. The positive rates of only high-risk and low-risk types of HPV were 60. 90% and 23.67% respectively. Positive rate of mixed infection with high and low-risk types HPV was 15.43%. The infection rates of high-risk type HPV in different age groups were from 26.39% to 42. 19%. The infection rates of low-risk type HPV in different age groups were from 8.96% to 39. 19%. Both the groups showed a "U" trend. Conclusions HPV16 infec- tion is the dominant type in different age groups. Low age groups were mainly mixed infected with high and low-risk HPV.≥55 years group was mainly infected with simple high-risk HPV; simple high-risk HPV in- fection rates rise with age.
出处 《国际病毒学杂志》 2013年第1期17-21,共5页 International Journal of Virology
关键词 人乳头瘤病毒 基因型 高危型 低危型 年龄 Human papilloma virus Genotypes High-risk type Low-risk type Age
  • 相关文献

参考文献15

二级参考文献110

共引文献185

同被引文献45

  • 1Stanley M. Pathology and epidemiology of HPV infection in Fe- males [ J]. Gynecologic Oncology, 2010, 117 ( Suppl 2) : S5-10.
  • 2Franceschi S. The IARC commitment to cancer prevention the ex- ample of papilomavirus and cervical cancer [ J ]. Recent Results Cancer Research, 2005, 116 (10) : 277-297.
  • 3Li S, Meng Y H, Ting H, et al. Clinical significance of human papilloma virus infection in the cervical lesions [ J ]. Front Math China, 2010, 4(3): 264-270.
  • 4Oh JK, Franceschi S, Kim BK, et al. Prevalence of human papil- lomavirus and Chlamydia trachomatis infection among women atten- ding cervical cancer screening in the Republic of Korea[ J]. Euro- pean Journal of Cancer Prevention, 2009, 18( 1 ) : 56-61.
  • 5Arbyn M, Dillner J. Review of current knowledge on HPV vacci- nation: An Appendix to the European guidelines for quality assur- ance in cervical cancer screening [ J]. J Clin Virol, 2007, 38 (3) : 189-197.
  • 6Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence sur- veys a pooled analysis [ J ]. Lancet, 2005, 366 (9490) : 991-998.
  • 7Ferlay JI, Shin HR, Bray F, et al. Estimates of worldwide bur- den of cancer in 2008: GLOBOCAN 2008 [ J]. Int J Cancer, 2010, 127 (12) : 2893-2917.
  • 8Syrjanen KJ. HPV infections and oesophageal cancer [ J ]. J Clin Patbol, 2002, 55 (10) : 721-728.
  • 9Letian T, Tianyu Z. Cellular receptor binding and entry of humanpapillomavirus [ J]. Virol J, 2010, 7: 2.
  • 10zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application [ J]. Nat Rev Cancer, 2002, 2 (5): 342-350.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部